$ICLR

ICON PLC

ICON is a contract research organization based in Dublin, Ireland, that provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, government and public health organizations. Its services cover clinical development from strategy, planning and trial design through study execution and post-market work, as well as consulting, functional outsourcing and laboratory services. Clinical development offerings include Phases I-IV, peri- and post-approval services, data solutions, and site and patient access. Laboratory testing includes bio-analytical, biomarker, vaccine, GMP and central laboratory services. ICON earns revenue by providing services that support clinical development, including clinical trial management, consulting, contract staffing, data solutions and laboratory services. It works through strategic partnerships, preferred-provider arrangements, full-service delivery, functional service provision and standalone services. Its brands and offerings include the Accellacare clinical research network and Accellacare In-Home Services. At December 31, 2025, ICON employs approximately 40,100 people in 97 locations in 55 countries.

No enriched coverage for $ICLR in the last 7 days.

—
$4.2M
Lyons Emer
0%
See all $ICLR insider activity →

Balfe Barry Edward sold $1.1M of ICLR

Balfe Barry Edward (Chief Executive Officer) sold 5,175 shares of ICON PLC (ICLR) at an average of $206.66 ($204.91–$209.53, $1.07M total) across 5 trades on 2026-11-02.

ICLR sentiment & insider activity

Recent ICLR coverage spans insider activity, earnings and market movers.

In the last 30 days, ICLR insiders filed 22 SEC Form 4 transactions — no purchases and 22 sales ($4.2M). The most active reporter was Lyons Emer, Chief Accounting Officer, with 10 filings.

What's driving ICLR

AlphAI scores every news story that mentions ICLR with an AI model for sentiment and relevance, and aggregates insider trades from ICON PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ICLR

Score
$ICLRHighEarnings

ICON PLC (ICLR): Financial results for Q3 2026

ICON PLC (ICLR) furnished an SEC Form 6-K — earnings release. 1 ICON Reports Third Quarter 2026 Results Third Quarter 2026 Key Highlights ▪ Strong commercial performance with net business wins in the quarter of $3,150 million; a net book- to-bill of 1.56 x and closing backlog of $24.5 billion, up 4.8% sequentially. ▪ Revenue of $2,024.8 mil

Related tickers